RE:RE:RE:To all the long time old timers here That is the big fear. According to this 2018 report – after the fact payoffs to FDA panel members are common. That would be a huge incentive for advisors to favour big pharma in their decisions. TLT – consistently poised on the edge of bankruptcy – would appear to be an unlikely source of gratitudinous plums.
https://www.science.org/content/article/hidden-conflicts-pharma-payments-fda-advisers-after-drug-approvals-spark-ethical